Skip to main content
SpringerLink
Log in

Primary Sjögren’s syndrome in Moroccan patients: characteristics, fatigue and quality of life

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Our aim was to evaluate fatigue and quality of life (QoL) in Moroccan patients with primary Sjögren’s syndrome (PSS) and determine their correlates with disease-related parameters. Fifty-seven consecutive patients with PSS according to the American-European Consensus group (AEGG) criteria were included. Demographic, clinical, biological and immunological characteristics for all patients were collected. Xerostomia was demonstrated by histological grading of lower lip glandular biopsy. A Schirmer test was performed to measure lachrymal flow. Oral, ocular, skin, vaginal and tracheal dryness were evaluated by using a visual analogue scale (VAS). Fatigue was assessed by the Multidimensional assessment of fatigue (MAF) and the QoL by using the generic instrument: SF-36. 90% of our patients were women. The mean age of patients was 53.73 ± 7.69 years, and the mean disease duration was 5.38 ± 4.11 years. The mean oral dryness was 68.38 ± 20.29, and the mean ocular dryness was 51.91 ± 14.03. The mean total score of the MAF was 26.73 ± 8.33, and 87.5% of our patients experienced severe fatigue. Also, physical and mental domains of QoL were altered in a significant way, and the severity of fatigue had a negative impact on SF-36 scores. MAF and SF-36 scores were correlated with the delay of diagnosis, the intensity of xerostomia and the activity of joint involvement. A low socioeconomic and educational level had a negative impact on fatigue scores and QoL. Histological grading of lower lip glandular biopsy, immunological status and the severity of systemic involvement had no correlations with fatigue scores or the alteration of QoL. Patients receiving antidepressant have lesser fatigue and those receiving Methotrexate have better SF-36 scores. In our data, there was a high prevalence of fatigue in Moroccan patients with PSS associated with altered QoL. Severe fatigue and reduced QoL seem to be related to the severity of joint involvement, xerostomia and both educational and socioeconomic levels. Also, treatment with methotrexate and antidepressant seems to improve patients’ living and QoL. An appropriate therapeutic intervention for depression and articular manifestations in PSS should be applied to improve patients’ living.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Carsons S (2001) A review and update of Sjögren’s syndrome: manifestations, diagnosis, and treatment. Am J Manag Care 7(14 Suppl):433–443

    Google Scholar 

  2. Segal B, Thomas W, Rogers T, Leon JM, Hughes P, Patel D, Patel K, Novitzke J, Rohrer M, Gopalakrishnan R, Myers S, Nazmul-Hossain A, Emamian E, Huang A, Rhodus N, Moser K (2008) Prevalence, severity, and predictors of fatigue in subjects with primary Sjögren’s syndrome. Arthritis Rheum 59(12):1780–1787

    Article  PubMed  Google Scholar 

  3. Fox RI (2005) Sjögren’s syndrome. Lancet 366(9482):321–331

    Article  PubMed  CAS  Google Scholar 

  4. Fox RI, Stern M, Michelson P (2000) Update in Sjögren syndrome. Curr Opin Rheumatol 12(5):391–398

    Article  PubMed  CAS  Google Scholar 

  5. Thomas E, Hay EM, Hajeer A, Silman AJ (1998) Sjögren’s syndrome: a community-based study of prevalence and impact. Br J Rheumatol 37(10):1069–1076

    Article  PubMed  CAS  Google Scholar 

  6. Oxholm P, Asmussen K (1995) Classification of disease manifestations in primary Sjögren’s syndrome: present status and a new proposal. Clin Rheumatol 14(Suppl 1):3–7

    PubMed  Google Scholar 

  7. Tensing EK, Solovieva SA, Tervahartiala T, Nordström DC, Laine M, Niissalo S, Konttinen YT (2001) Fatigue and health profile in sicca syndrome of Sjögren’s and non-Sjögren’s syndrome origin. Clin Exp Rheumatol 19(3):313–316

    PubMed  CAS  Google Scholar 

  8. Bowman SJ (2002) Collaborative research into outcome measures in Sjögren’s syndrome. Update on disease assessment. Scand J Rheumatol Suppl 116:23–27

    Article  PubMed  CAS  Google Scholar 

  9. Harboe E, Tjensvoll AB, Vefring HK, Gøransson LG, Kvaløy JT, Omdal R (2009) Fatigue in primary Sjögren’s syndrome–a link to sickness behaviour in animals? Brain Behav Immun 23(8):1104–1108

    Article  PubMed  CAS  Google Scholar 

  10. Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, Ogale S, McLean L (2009) Primary Sjögren’s Syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes 7:46

    Article  PubMed  Google Scholar 

  11. Bowman SJ (2008) Patient-reported outcomes including fatigue in primary Sjögren’s syndrome. Rheum Dis Clin North Am 34(4):949–962

    Article  PubMed  Google Scholar 

  12. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome (2002) Classification criteria for Sjögren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 61(6):554–558

    Article  PubMed  CAS  Google Scholar 

  13. Neuberger GB (2003) Measures of fatigue. Arthritis Rheum 49:175–183

    Article  Google Scholar 

  14. Bowman SJ, Booth DA, Platts RG, UK Sjögren’s Interest Group (2004) Measurement of fatigue and discomfort in primary Sjogren’s syndrome using a new questionnaire tool. Rheumatology (Oxford) 43(6):758–764

    Article  CAS  Google Scholar 

  15. Khoudri I, Ali Zeggwagh A, Abidi K, Madani N (2007) Abouqal R Measurement properties of the short form 36 and health-related quality of life after intensive care in Morocco. Acta Anaesthesiol Scand 51(2):189–197

    Article  PubMed  CAS  Google Scholar 

  16. Strömbeck B, Theander E, Jacobsson LT (2005) Assessment of fatigue in primary Sjögren’s syndrome: the Swedish version of the Profile of Fatigue. Scand J Rheumatol 34(6):455–459

    Article  PubMed  Google Scholar 

  17. Lwin CT, Bishay M, Platts RG, Booth DA, Bowman SJ (2003) The assessment of fatigue in primary Sjögren’s syndrome. Scand J Rheumatol 32(1):33–37

    Article  PubMed  Google Scholar 

  18. Barendregt PJ, Visser MR, Smets EM, Tulen JH, van den Meiracker AH, Boomsma F, Markusse HM (1998) Fatigue in primary Sjögren’s syndrome. Ann Rheum Dis 57(5):291–295

    Article  PubMed  CAS  Google Scholar 

  19. Giles I, Isenberg D (2000) Fatigue in primary Sjögren’s syndrome: is there a link with the fibromyalgia syndrome? Ann Rheum Dis 59(11):875–878

    Article  PubMed  CAS  Google Scholar 

  20. Godaert GL, Hartkamp A, Geenen R, Garssen A, Kruize AA, Bijlsma JW, Derksen RH (2002) Fatigue in daily life in patients with primary Sjögren’s syndrome and systemic lupus erythematosus. Ann N Y Acad Sci 966:320–326

    Article  PubMed  CAS  Google Scholar 

  21. Smets EM, Garssen B, Bonke B, De Haes JC (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315–325

    Article  PubMed  CAS  Google Scholar 

  22. d’Elia HF, Rehnberg E, Kvist G, Ericsson A, Konttinen Y, Mannerkorpi K (2008) Fatigue and blood pressure in primary Sjogren’s syndrome. Scand J Rheumatol 37(4):284–292

    Article  PubMed  Google Scholar 

  23. Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P (2008) Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis 67(11):1541–1544

    Article  PubMed  CAS  Google Scholar 

  24. Calabrese LH, Davis ME, Wilke WS (1994) Chronic fatigue syndrome and a disorder resembling Sjögren’s syndrome: preliminary report. Clin Infect Dis 18(Suppl 1):28–31

    Article  Google Scholar 

  25. Bax HI, Vriesendorp TM, Kallenberg CG, Kalk WW (2002) Fatigue and immune activity in Sjögren’s syndrome. Ann Rheum Dis 61(3):284

    Article  PubMed  CAS  Google Scholar 

  26. Barry RJ, Sutcliffe N, Isenberg DA, Price E, Goldblatt F, Adler M, Canavan A, Hamburger J, Richards A, Regan M, Gadsby K, Rigby S, Jones A, Mathew R, Mulherin D, Stevenson A, Nightingale P, Rauz S, Bowman SJ (2008) The Sjögren’s Syndrome Damage Index—a damage index for use in clinical trials and observational studies in primary Sjögren’s syndrome. Rheumatology (Oxford) 47(8):1193–1198

    Article  CAS  Google Scholar 

  27. Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C, Bergé E, Pellet J, Hardy P, Mariette X (2006) Quality of life and psychological status in patients with primary Sjögren’s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 55(3):451–457

    Article  PubMed  Google Scholar 

  28. Strömbeck B, Ekdahl C, Manthorpe R, Wikström I, Jacobsson L (2000) Health-related quality of life in primary Sjögren’s syndrome, rheumatoid arthritis and fibromyalgia compared to normal population data using SF-36. Scand J Rheumatol 29(1):20–28

    Article  PubMed  Google Scholar 

  29. Vriezekolk JE, Geenen R, Hartkamp A, Godaert GL, Bootsma H, Kruize AA, Bijlsma JW, Derksen RH (2005) Psychological and somatic predictors of perceived and measured ocular dryness of patients with primary Sjögren’s syndrome. J Rheumatol 32(12):2351–2355

    PubMed  Google Scholar 

  30. Inal V, Kitapcioglu G, Karabulut G, Keser G, Kabasakal Y (2010) Evaluation of quality of life in relation to anxiety and depression in primary Sjögren’s syndrome. Mod Rheumatol [Epub ahead of print]

  31. Kamel UF, Maddison P, Whitaker R (2009) Impact of primary Sjogren’s syndrome on smell and taste: effect on quality of life. Rheumatology (Oxford) 48(12):1512–1514

    Article  Google Scholar 

  32. Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, Bootsma H (2009) Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology (Oxford) 48(9):1077–1082

    Article  Google Scholar 

  33. Rostron J, Rogers S, Longman L, Kaney S, Field EA (2002) Health-related quality of life in patients with primary Sjögren’s syndrome and xerostomia: a comparative study. Gerodontology 19(1):53–59

    Article  PubMed  Google Scholar 

  34. Turan Y, Duruöz MT, Cerrahoglu L (2007) Quality of life in patients with ankylosing spondylitis: a pilot study. Rheumatol Int 27:895–899

    Article  PubMed  Google Scholar 

  35. Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W (2009) The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes 7:25

    Article  PubMed  Google Scholar 

  36. Stewart CM, Berg KM, Cha S, Reeves WH (2008) Salivary dysfunction and quality of life in Sjögren syndrome: a critical oral-systemic connection. J Am Dent Assoc 139(3):291–299

    PubMed  Google Scholar 

  37. Fauchais AL, Ouattara B, Gondran G, Lalloué F, Petit D, Ly K, Lambert M, Launay D, Loustaud-Ratti V, Bezanahari H, Liozon E, Hachulla E, Jauberteau MO, Vidal E, Hatron PY (2010) Articular manifestations in primary Sjögren’s syndrome: clinical significance and prognosis of 188 patients. Rheumatology (Oxford) 49(6):1164–1172

    Article  Google Scholar 

  38. Georges C, Chassany O, Mouthon L, Tiev K, Marjanovic Z, Meyer O, Toledano C, Ilie D, Guillevin L, Sereni D, Cabane J, Farge D (2004) Quality of life assessment with the MOS-SF36 in patients with systemic sclerosis. Rev Med Interne 25(1):16–21

    Article  PubMed  CAS  Google Scholar 

  39. Pollard LC, Choy EH, Gonzalez J, Khoshaba B, Scott DL (2006) Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford) 45(7):885–889

    Article  CAS  Google Scholar 

  40. Strand V, Scott DL, Emery P, Kalden JR, Smolen JS, Cannon GW, Tugwell P, Crawford B (2005) Leflunomide Rheumatoid Arthritis Investigators Groups, Physical function and health related quality of life: analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis. J Rheumatol 32(4):590–601

    PubMed  CAS  Google Scholar 

  41. Söderlin MK, Lindroth Y, Jacobsson LT (2007) Trends in medication and health-related quality of life in a population-based rheumatoid arthritis register in Malmo, Sweden. Rheumatology (Oxford) 46(8):1355–1358

    Article  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Rheumatology (Pr N. Hajjaj-Hassouni), El Ayachi Hospital, University Hospital of Rabat-Sale, 11000, Sale, Morocco

    Yousra Ibn Yacoub, Samira Rostom, Assia Laatiris & Najia Hajjaj-Hassouni

Authors
  1. Yousra Ibn Yacoub
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Samira Rostom
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Assia Laatiris
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Najia Hajjaj-Hassouni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yousra Ibn Yacoub.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ibn Yacoub, Y., Rostom, S., Laatiris, A. et al. Primary Sjögren’s syndrome in Moroccan patients: characteristics, fatigue and quality of life. Rheumatol Int 32, 2637–2643 (2012). https://doi.org/10.1007/s00296-011-2009-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-011-2009-5

Keywords

Search

Navigation